Two executives with ties to President Donald Trump and Trump Media & Technology Group (NASDAQ:DJT) have a new SPAC offering ...

Irish businessman Gary Quin has successfully floated a new special purpose investment company (Spac) on New York’s Nasdaq, raising $220m (€197m). This was more than the $200m it originally intended to ...

Swiss biotech investor Xlife Sciences AG said on Wednesday its portfolio company Veraxa Biotech AG would list on U.S. exchange Nasdaq in a $1.64 billion merger deal with a special-purpose acquisition ...

Zurich-based start-up Veraxa Biotech has reached a deal to merge with special purpose acquisition company (SPAC) Voyager, gaining a listing on the Nasdaq that will give it a valuation of around $1 ...

Market turmoil may have frozen the traditional IPO pipeline, but German antibody biotech Veraxa is turning to the special purpose acquisition company (SPAC) model to hop onto the Nasdaq.